Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
08. Februar 2022 17:27 ET
|
Telix Pharmaceuticals Limited
MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based...
FDA Approves Phase II Kidney Cancer Therapy Study
13. September 2021 18:41 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
17. August 2021 21:03 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
17. August 2021 21:02 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
29. August 2019 20:00 ET
|
Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
29. August 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
14. Oktober 2018 18:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer
23. August 2018 19:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”) has today announced a research collaboration with the University of Melbourne...
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market
15. August 2018 19:00 ET
|
Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
テリックス･ファーマシューティカルズとjfe、日本の製造パートナーシップを進める
25. Juli 2018 19:00 ET
|
Telix Pharmaceuticals Limited
メルボルン , July 26, 2018 (GLOBE NEWSWIRE) -- および京都発 (グローブニューズワイヤ) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用･治療用製品の開発に注力するオーストラリアのバイオ製薬会社であるテリックス･ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX:TLX)...